share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股SEC公告 ·  08/08 12:59
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 20,000 Class A shares of the company, with an aggregate market value of $130,000, on 08/08/2024. These shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. Over the past three months, Gibson has sold a total of 230,000 shares, generating gross proceeds of $1,831,500. The upcoming sale continues a pattern of divestment by Gibson, although the detailed history of these transactions is not provided in this summary.
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 20,000 Class A shares of the company, with an aggregate market value of $130,000, on 08/08/2024. These shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. Over the past three months, Gibson has sold a total of 230,000 shares, generating gross proceeds of $1,831,500. The upcoming sale continues a pattern of divestment by Gibson, although the detailed history of these transactions is not provided in this summary.
Recursion Pharmaceuticals, Inc.官員和董事Christopher Gibson計劃出售該公司20,000股A類股票,市場總價值爲130,000美元,出售日期爲2024年8月8日。 這些股票最初是在2016年9月1日作爲創始股票獲得的一種補償方式。 在過去的三個月中,Gibson已賣出230,000股股票,總收益爲1,831,500美元。 即將到來的銷售繼續了Gibson的減持模式,儘管這些交易的詳細歷史在本概要中沒有提供。
Recursion Pharmaceuticals, Inc.官員和董事Christopher Gibson計劃出售該公司20,000股A類股票,市場總價值爲130,000美元,出售日期爲2024年8月8日。 這些股票最初是在2016年9月1日作爲創始股票獲得的一種補償方式。 在過去的三個月中,Gibson已賣出230,000股股票,總收益爲1,831,500美元。 即將到來的銷售繼續了Gibson的減持模式,儘管這些交易的詳細歷史在本概要中沒有提供。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息